Related references
Note: Only part of the references are listed.The role of flavonoids in autoimmune diseases: Therapeutic updates
Kannan R. R. Rengasamy et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Novel paradigms in systemic lupus erythematosus
Thomas Doerner et al.
LANCET (2019)
Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity
Aysooda Hosseinzade et al.
FRONTIERS IN IMMUNOLOGY (2019)
Quercetin attenuates collagen-induced arthritis by restoration of Th17/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect
Yan Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice
Junpeng Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)
Naringenin is an inhibitor of T cell effector functions
Xinli Niu et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)
A Review on Pharmacological and Analytical Aspects of Naringenin
Kanika Patel et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2018)
Naringenin as a potential immunomodulator in therapeutics
Wenfeng Zeng et al.
PHARMACOLOGICAL RESEARCH (2018)
Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments
Zahi Touma et al.
LUPUS SCIENCE & MEDICINE (2017)
The role of icaritin in regulating Foxp3/IL17a balance in systemic lupus erythematosus and its effects on the treatment of MRL/lpr mice
Jieyue Liao et al.
CLINICAL IMMUNOLOGY (2016)
Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation
Fang Lin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks
O. P. Rekvig
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Regulatory T cells in systemic lupus erythematosus
Kim Ohl et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Emerging biological therapies for systemic lupus erythematosus
Chi Chiu Mok
EXPERT OPINION ON EMERGING DRUGS (2014)
Effect of Proinflammatory Cytokines (IL-6, TNF-alpha, and IL-1 beta) on Clinical Manifestations in Indian SLE Patients
Vinod Umare et al.
MEDIATORS OF INFLAMMATION (2014)
Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
Hui Peng et al.
CLINICAL RHEUMATOLOGY (2013)
Autoimmune effector memory T cells: the bad and the good
Priyadharshini Devarajan et al.
IMMUNOLOGIC RESEARCH (2013)
Supplemental Naringenin Prevents Intestinal Barrier Defects and Inflammation in Colitic Mice
Tomoyo Azuma et al.
JOURNAL OF NUTRITION (2013)
Regulatory T cells in systemic lupus erythematosus (SLE); Role of peptide tolerance
Priya Sawla et al.
AUTOIMMUNITY REVIEWS (2012)
Serum cytokine profile in patients with active lupus nephritis
Katrin Franzika Koenig et al.
CYTOKINE (2012)
Urinary Biomarkers in Lupus Nephritis
Joyce Reyes-Thomas et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
Current and novel therapeutics in the treatment of systemic lupus erythematosus
Cagri Yildirim-Toruner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Inflammatory Cytokines in Systemic Lupus Erythematosus
Kim Ohl et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Murine Models of Systemic Lupus Erythematosus
Daniel Perry et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells
Clemens Scheinecker et al.
JOURNAL OF AUTOIMMUNITY (2010)
Anti-TNF-alpha Therapies in Systemic Lupus Erythematosus
Lang-Jing Zhu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Contemporary treatment of systemic lupus erythematosus: an update for clinicians
Maame B. Amissah-Arthur et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2010)
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
Claudio Ponticelli et al.
PHARMACEUTICALS (2010)
Indole-3-carbinol improves survival in lupus-prone mice by inducing tandem B- and T-cell differentiation blockades
Xiao-jie Yan et al.
CLINICAL IMMUNOLOGY (2009)
Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lprllpr mice
Y. H. Hong et al.
LUPUS (2008)
Systemic lupus erythematosus
David P. D'Cruz et al.
LANCET (2007)
Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus
Yansong Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Abnormal differentiation of memory T cells in systemic lupus erythematosus
Ruth D. Fritsch et al.
ARTHRITIS AND RHEUMATISM (2006)
Genomic view of systemic autoimmunity in MRLlpr mice
J Liu et al.
GENES AND IMMUNITY (2006)
MRL/Mp CD4+,CD25-T cells show reduced sensitivity to suppression by CD4+,CD25+regulatory T cells in vitro - A novel defect of T cell regulation in systemic lupus erythematosus
CR Monk et al.
ARTHRITIS AND RHEUMATISM (2005)
Regulatory T cells: Friend or foe in immunity to infection?
KHG Mills
NATURE REVIEWS IMMUNOLOGY (2004)
Rationale for interleukin-6 blockade in systemic lupus erythematosus
E Tackey et al.
LUPUS (2004)
Quantification of regulatory T cells in patients with systemic lupus erythematosus
JC Crispin et al.
JOURNAL OF AUTOIMMUNITY (2003)
Share Paper
